Development of chronic colitis is dependent on the cytokine MIFYpe P. de Jong, Cox Terhorst, Andrew C. Keates et al.|Nature Immunology|2001Cited by 311
The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory AgentsJodi B. Lubetsky, Yousef Al‐Abed, Angeles Dios et al.|Journal of Biological Chemistry|2002Cited by 298
Pro-1 of Macrophage Migration Inhibitory Factor Functions as a Catalytic Base in the Phenylpyruvate Tautomerase Activity<sup>,</sup>Jodi B. Lubetsky, Elias Lolis, Melissa D. Swope et al.|Biochemistry|1999Cited by 166
Macrophage Migration Inhibitory Factor Promotes Intestinal TumorigenesisJonathan M. Wilson, Mark A. Hull, P. Louise Coletta et al.|Gastroenterology|2005Cited by 147
Inhibition of MIF Bioactivity by Rational Design of Pharmacological Inhibitors of MIF Tautomerase ActivityAngeles Dios, Yousef Al‐Abed, Robert A. Mitchell et al.|Journal of Medicinal Chemistry|2002Cited by 125